Skip to main content
SpringerLink
Log in

Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background and Purpose

It is unclear whether prior therapy with antiplatelet agents (APA) is associated with a better outcome in patients with acute ischemic cerebrovascular events.

Methods

Within a multi–center cross–sectional study, nested in a cohort we analyzed the relation between prior therapy with APA and stroke severity in 1643 patients with acute ischemic stroke or TIA. Clinical severity of the vascular event was evaluated by the National Institutes of Health Stroke Scale on admission (NIHSS1) and after 1 week (NIHSS2). By means of analysis of variance we analyzed a possible association of APA with stroke severity and interactions regarding stroke severity between APA and other clinical measures.

Results

475 patients (29 %) received aspirin prior to the cerebrovascular event, 51 patients (3 %) ticlopidine or clopidogrel and 26 patients (1.6%) aspirin combined with extended release dipyridamole. 66% (1091) of patients did not take any antiplatelet medication. Neither the NIHSS1 nor the NIHSS2 nor the change of stroke severity between these time points (NIHSS1– NIHSS2) was associated with prior APA medication. We did not find significant interactions between APA use and clinical measures regarding stroke severity.

Conclusions

Our results do not indicate that prior therapy with APA is associated with a better outcome in acute ischemic cerebrovascular events. There were no interactions found with other features that were associated with stroke severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bhatt DL, Topol EJ, on behalf on the CHARISMA Executive committee (2004) Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high–risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 148:263–268

    Article  PubMed  CAS  Google Scholar 

  2. Blake AD (2004) Dipyridamole is neuroprotective for cultured rat embryonic cortical neurons. Biochem Biophys Res Commun 314:501–504

    Article  PubMed  CAS  Google Scholar 

  3. Carolei A, Prencipe M, Fiorelli M, Fieschi C (1986) Severity of stroke and aspirin. Neurology 36:1010–1011

    PubMed  CAS  Google Scholar 

  4. De Keyser J, Herroelen L, De Klippel N (1997) Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low–dose aspirin. J Neurol Sci 145:93–96

    Article  PubMed  CAS  Google Scholar 

  5. Farinelli SE, Greene LA, Friedman WJ (1998) Neuroprotective actions of dipyridamole on cultured cns neurons. J Neurosci 18:5112–5123

    PubMed  CAS  Google Scholar 

  6. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35:1688–1691

    Article  PubMed  CAS  Google Scholar 

  7. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of nf–kappa–b activation. Science 274:1383–1385

    Article  PubMed  CAS  Google Scholar 

  8. Grotta JC, Lemak NA, Gary H, Fields WS, Vital D (1985) Does platelet antiaggregant therapy lessen the severity of stroke? Neurology 35:632–636

    PubMed  CAS  Google Scholar 

  9. Joseph RHE, Grunfeld S, Welch KMA (1989) Prior use of aspirin may reduce stroke severity. Ann Neurol 26:131

    Google Scholar 

  10. Kalra L, Perez I, Smithard DG, Sulch D (2000) Does prior use of aspirin affect outcome in ischemic stroke? Am J Med 108:205–209

    Article  PubMed  CAS  Google Scholar 

  11. Karepov V, Bornstein NM, Hass Y, Korczyn AD (1997) Does daily aspirin diminish severity of first–ever stroke? Arch Neurol 54:1369–1371

    PubMed  CAS  Google Scholar 

  12. Lalouschek W, Lang W, Müllner M, on behalf of the Vienna Stroke Study Group (2001) Current strategies of secondary prevention after a cerebrovascular event – the Vienna stroke registry. Stroke 32:2860–2866

    PubMed  CAS  Google Scholar 

  13. Lang W, Lalouschek W (2001) The Vienna Stroke Registry – objectives and methodology. Wien Klin Wochenschr 113:141–147

    Google Scholar 

  14. Quinn MJ, Bhatt DL, Zidar F, Vivekananthan D, Chew DP, Ellis SG, Plow E, Topol EJ (2004) Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol 93:679–684

    Article  PubMed  CAS  Google Scholar 

  15. Rosenblum WI, El–Sabban F (1977) Platelet aggregation in the cerebral microcirculation: Effect of aspirin and other agents. Circ Res 40:320–328

    PubMed  CAS  Google Scholar 

  16. Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P (1999) Antiplatelet treatment does not reduce the severity of subsequent stroke. European stroke prevention study 2 working group. Neurology 53:825–829

    PubMed  CAS  Google Scholar 

  17. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD (2001) Effect of prior aspirin use on stroke severity in the trial of org 10172 in acute stroke treatment (TOAST). Stroke 32:2836–2840

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology Medical, University of Vienna, Waehringer Guertel 18–20, 1097, Vienna, Austria

    S. Greisenegger MD, S. Tentschert MD &  W. Lalouschek MD

  2. Department of Radiology Medical, University of Vienna, Waehringer Guertel 18–20, 1097, Vienna, Austria

    M. Weber PhD

  3. Department of Neurology, Krankenhaus der Barmherzigen Brüder, Waehringer Guertel 18–20, 1097, Vienna, Austria

    J. Ferrari MD & W. Lang MD

Authors
  1. S. Greisenegger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Tentschert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Weber PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Ferrari MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Lang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Lalouschek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Lalouschek MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greisenegger, S., Tentschert, S., Weber, M. et al. Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA. J Neurol 253, 648–652 (2006). https://doi.org/10.1007/s00415-006-0088-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0088-0

Key words

Search

Navigation